Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Canadian veterinary journal = La revue veterinaire canadienne

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 30510312PMCID PMC6135299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Withrow and MacEwen's Small Animal Clinical Oncology

  2020cited by this paper
• 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

  2017cited by this paper
• Medical error—the third leading cause of death in the US

  2016cited by this paper
• Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.

  2016cited by this paper
• 2016 AAHA Oncology Guidelines for Dogs and Cats.

  2016cited by this paper
• Efficacy of Intravenous Administration of Combined Acid Suppressants in Healthy Dogs

  2015cited by this paper
• Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

  2015cited by this paper
• Dexrazoxane for the treatment of chemotherapy-related side effects

  2014cited by this paper
• Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

  2014cited by this paper
• Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.

  2012cited by this paper
• Glutamine for chemotherapy induced diarrhea: a meta-analysis.

  2012cited by this paper
• Extravasation management: clinical update.

  2011cited by this paper
• RhG-CSF improves radiation-induced myelosuppression and survival in the canine exposed to fission neutron irradiation.

  2011cited by this paper
• Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient.

  2010cited by this paper
• Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

  2010cited by this paper
• Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.

  2010cited by this paper
• Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.

  2010cited by this paper
• Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity.

  2009cited by this paper
• Chemotherapy: managing side effects and safe handling.

  2009cited by this paper
• Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.

  2008cited by this paper
• European Oncology Nursing Society extravasation guidelines.

  2008cited by this paper
• Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

  2007cited by this paper
• Beneficial effect of enteral feeding.

  2007cited by this paper
• Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone

  2005cited by this paper
• Long‐Term Clinical Outcome After Accidental Overdose of Multiple Chemotherapeutic Agents

  2005cited by this paper
• Sax's Dangerous Properties of Industrial Materials Eleventh Edition CD-ROM Networkable Version 11+ Users

  2005cited by this paper
• Plumb's Veterinary Drug Handbook

  2005cited by this paper
• Chemotherapy and Biotherapy: Guidelines and Recommendations for Practice

  2001cited by this paper
• Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

  2001cited by this paper
• Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.

  1998cited by this paper
• Accidental doxorubicin overdosage.

  1995cited by this paper
• Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs.

  1992cited by this paper
• Acute doxorubicin overdoses.

  1991cited by this paper
• Cancer Chemotherapy

  1968cited by this paper

• A Retrospective Study of Chemotherapy‐Related Extravasation Events in Dogs and Cats

  2025cites this paper
• Phlebitis in Veterinary Patients

  2025cites this paper
• Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma

  2022cites this paper
• A Retrospective Evaluation of Chemotherapy Overdoses in Dogs and Cats

  2021cites this paper
• Toxicity, outcome, and management of anthracycline overdoses in 16 dogs

  2021cites this paper